| 31.10 07:55 | dpa-AFX: Takeda H1 Profit Rises; Upgrades 2024 Management Guidance |
| 31.10 07:11 | dpa-AFX: *TAKEDA NOW EXPECTS FY24 EPS OF 43 YEN, CORE EPS OF 456 YEN |
| 31.10 07:11 | dpa-AFX: *TAKEDA NOW EXPECTS FY24 REVENUE OF 4.480 TRLN YEN |
| 31.10 07:10 | dpa-AFX: *TAKEDA H1 REVENUE $2.384 TRLN YEN VS. 2.101 TRLN YEN LAST YEAR |
| 31.10 07:10 | dpa-AFX: *TAKEDA H1 CORE EPS 310 YEN VS. 261 YEN LAST YEAR |
| 31.10 07:09 | dpa-AFX: *TAKEDA H1 NET INCOME 187.3 BLN YEN VS. 41.4 BLN YEN LAST YEAR |
| 31.10 07:09 | dpa-AFX: *TAKEDA H1 OPERATING PROFIT 350.6 BLN YEN VS. 119.2 BLN YEN LAST YEAR |
| 31.10 07:08 | dpa-AFX: *TAKEDA H1 EPS 119 YEN VS. 27 YEN LAST YEAR |
| 31.10 07:01 | EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2024 (IFRS) |
| 31.10 07:01 | EQS-Adhoc: Takeda Pharmaceutical Company Limited: -2- |
| 31.10 07:01 | dpa-AFX: EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2024 (IFRS) (english) |
| 31.10 07:01 | dpa-AFX: EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2024 (IFRS) (english) |
| 31.10 07:00 | EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2024 (IFRS) |
| 31.10 07:00 | EQS-Adhoc: Takeda Pharmaceutical Company Limited: -2- |
| 24.10 14:16 | dpa-AFX: *TAKEDA AND BOSTON MEDICAL CENTER ANNOUNCE COLLABORATION TO HELP TACKLE DECARBONIZATION ACROSS HEALTH CARE ECOSYSTEM |
| 31.07 08:45 | dpa-AFX: Takeda Q1 Profit Increases; Backs FY Outlook |
| 31.07 08:20 | dpa-AFX: *TAKEDA EXPECTS FY24 EPS OF 37 YEN, CORE EPS OF 431 YEN |
| 31.07 08:20 | dpa-AFX: *TAKEDA Q1 CORE OPERATING PROFIT 382.3 BLN YEN VS. 326.3 BLN YEN LAST YEAR |
| 31.07 08:20 | dpa-AFX: *TAKEDA EXPECTS FY24 REVENUE OF 4.350 TRLN YEN |
| 31.07 08:19 | dpa-AFX: *TAKEDA Q1 CORE EPS 176 YEN VS. 150 YEN LAST YEAR |
|
|
